SHZ:000078

Shenzhen Neptunus Bioengineering Co., Ltd. · SHZ · Healthcare · CNY · FY for 2025

Figures on this page computed 2026-11-08 12:50 UTC

Last close

n/aCNY

Market data

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
-2.1%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
-0.1%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
9.41Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
15.5%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed

Safety is the furthest below its sector's middle: 0.19 against 0.58 on the market's range.

Five bars, one line

lens 7 of 9

0.81x

1.88x

0.10x

1.09x

n/a

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Computed2025

Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

Sales0.81x
Its own average over 10 years, 33.07B.
Profit1.88x
Its own average over 10 years, -299.3M.
Free cash flow0.10x
Its own average over 10 years, -223.4M.
Debt1.09x
Its own average over 10 years, 10.59B.
Pricen/a
Its own average over 0 years. Market data

Free cash flow is furthest from its own average, at 0.10 times.

Sales is 0.81 times its own 10-year average; Profit is 1.88 times its own 10-year average; Free cash flow is 0.10 times its own 10-year average; Debt is 1.09 times its own 10-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales against its own 10-year average0.81
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Profit against its own 10-year average1.88
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Free cash flow against its own 10-year average0.10
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Debt against its own 10-year average1.09
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Price against its own 0-year averagen/aMarket data
Not held.
Source
market
Reported in
CNY